J Nucl Med 1999 Apr;40(4):591-603
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer,
lymphoma and melanoma.
Delbeke D.
Department of Radiology and Radiological Sciences, Vanderbilt University Medical
Center, Nashville, Tennessee 37232-2675, USA.
This article will focus primarily on body oncology diagnosis, staging and
therapy monitoring using fluorodeoxyglucose (FDG) PET imaging. Common pitfalls
and artifacts in body FDG imaging will be covered. Examples of diagnosis,
staging and therapy monitoring of brain tumor, colorectal cancer, lymphoma and
melanoma will be given. Importance of correlation with anatomic imaging and
practical use of FDG imaging in patient management will be stressed.
